BMC Geriatrics

, 10:A92 | Cite as

Cutaneus cancers in elderly Medical treatment of actinic keratosis and superficial coutaneus cancers: imiquimod

  • M N Dastoli
Open Access
Meeting abstract


Public Health Carcinoma Adverse Event Cell Carcinoma Medical Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


The aim of this work is to evaluate the efficacy and safety of imiquimod 5% cream used in the treatment of certain non-melanoma skin cancers.

Materials and methods

We treated 30 subjects: 5 actinic keratosis, 3 cheratoacanthomas, 5 cutaneous horns, 5 superficial basal cell carcinomas, 12 nodular basal cell carcinomas according to the therapeutic pattern - five applications a week for 6-12 weeks -. The patients with nodular forms could not be treated with surgery for severe chronic deseases, age, or refusal.


Imiquimod 5% cream was effective and well tolerated both in actinic keratosis and in superficial and nodular basal cell carcinoma.


The treatment of certain non-melanoma coutaneous toumors with imiquimod 5% cream, has been effective, without collateral effects; erythema, edema, vesicles, crusts and erosions with itching or burning in the application area, have been the most frequent adverse events which however did not cause the suspension of therapy.

A diligent and continuative follow-up is necessary.

Copyright information

© Dastoli; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Authors and Affiliations

  • M N Dastoli
    • 1
  1. 1.ASP Cosenza, Corigliano CalabroItaly

Personalised recommendations